Given these pro-resolving actions of ANXA1 in cerebrovascular disease, its reduction in the hippocampus of our HF-fed females could contribute to the worse vascular outcomes (lower CBF) and hippocampal-dependent cognitive deficits we previously observed. The gene discussed is ANXA1; the disease is Cognitive impairment.